Dengue Fever Surveillance in Mato Grosso do Sul: Insights from Genomic Analysis and Implications for Public Health Strategies.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
23 08 2023
Historique:
received: 17 07 2023
revised: 17 08 2023
accepted: 21 08 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Since its discovery in early 1916, dengue fever, a common vector-borne illness in Brazil, has resulted in extensive urban outbreaks and poses a serious threat to the public's health. Understanding the dynamics of Dengue Virus (DENV) serotypes circulating in different regions of Brazil is essential for implementing effective disease control and prevention measures. In response to this urgent need, we conducted an on-site training program in genomic surveillance in collaboration with the Central Laboratory of Health and the Secretary of Health of the Mato Grosso do Sul state. This initiative resulted in the generation of 177 DENV genome sequences collected between May 2021 and May 2022, a period during which over 11,391 dengue fever cases were reported in the state. Through this approach, we were able to identify the co-circulation of two different dengue serotypes (DENV1 and DENV2) as well as the existence of diverse viral lineages within each genotype, suggesting that multiple introduction events of different viral strains occurred in the region. By integrating epidemiological data, our findings unveiled temporal fluctuations in the relative abundance of different serotypes throughout various epidemic seasons, highlighting the complex and changing dynamics of DENV transmission throughout time. These findings demonstrate the value of ongoing surveillance activities in tracking viral transmission patterns, monitoring viral evolution, and informing public health actions.

Identifiants

pubmed: 37766197
pii: v15091790
doi: 10.3390/v15091790
pmc: PMC10536684
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI151698
Pays : United States

Références

Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Mol Biol Evol. 2013 Feb;30(2):239-43
pubmed: 23090976
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Cell Rep. 2020 Feb 18;30(7):2275-2283.e7
pubmed: 32075736
Bioinformatics. 2019 Mar 1;35(5):871-873
pubmed: 30124794
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Nat Commun. 2021 Apr 16;12(1):2296
pubmed: 33863880
Infect Genet Evol. 2023 Apr;109:105407
pubmed: 36764633
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Viruses. 2023 May 30;15(6):
pubmed: 37376575
Expert Rev Anti Infect Ther. 2012 Aug;10(8):895-907
pubmed: 23030329
Nat Commun. 2021 May 11;12(1):2619
pubmed: 33976183
Nat Microbiol. 2022 Sep;7(9):1490-1500
pubmed: 35982313
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734

Auteurs

Larissa Domingues Castilho de Arruda (LD)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.
Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.

Marta Giovanetti (M)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.
Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di, 00128 Roma, Italy.

Vagner Fonseca (V)

Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 70312-970, DF, Brazil.

Marina Castilhos Souza Umaki Zardin (MCSU)

SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Gislene Garcia de Castro Lichs (GGC)

SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Silvia Asato (S)

SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Ana Olivia Pascoto Esposito (AOP)

SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Miriam Tokeshi Müller (M)

SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Joilson Xavier (J)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.

Hegger Fritsch (H)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.

Mauricio Lima (M)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.

Carla de Oliveira (C)

lnstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil.

Elaine Vieira Santos (EV)

Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto 14051-140, SP, Brazil.

Livia de Mello Almeida Maziero (LMA)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.
Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.

Danila Fernanda Rodrigues Frias (DFR)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Danielle Ahad das Neves (D)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Liliane Ferreira da Silva (L)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.
Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.

Ellen Caroline Rodrigues Barretos (EC)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Paulo Eduardo Tsuha Oshiro (PE)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Bianca Modafari Goday (B)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Jéssica Klener Lemos Dos Santos (JK)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Simone Kashima (S)

Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto 14051-140, SP, Brazil.

Carlos F C de Albuquerque (CFC)

Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70312-970, DF, Brazil.

Rodrigo Fabiano do Carmo Said (RFDC)

Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70312-970, DF, Brazil.

Alexander Rosewell (A)

Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70312-970, DF, Brazil.

Luiz Henrique Ferraz Demarchi (LHF)

SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.

Julio Croda (J)

Fundação Oswaldo Cruz, Universidade Federal de Mato Grosso do Sul-UFMS, Campo Grande 79000-000, MS, Brazil.

Luiz Carlos Junior Alcantara (LCJ)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.

Crhistinne Cavalheiro Maymone Gonçalves (C)

Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil.
Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH